FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1440416 · Received August 14, 2009

Report

Report Number
2024168-2009-01475
Event Type
Injury
Date Received
August 14, 2009
Date of Event
June 28, 2009
Report Date
June 29, 2009
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DISSECTION, AS LISTED IN THE XIENCE V IFU, IS A KNOWN ADVERSE EVENT ASSOCIATED WITH CORONARY STENTING. DISSECTION CAN BE INFLUENCED BY SEVERAL FACTORS. THE IFU STATES: IMPLANTING A STENT MAY LEAD TO DISSECTION OF THE VESSEL DISTAL AND/OR PROXIMAL TO THE STENT AND MAY CAUSE ACUTE CLOSURE OF THE VESSEL REQUIRING ADDITIONAL INTERVENTION. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECT AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE DOES NOT APPEAR TO BE AN INDICATION OF A LOT SPECIFIC PRODUCT QUALITY DEFICIENCY. THE 2.75 X 23 MM XIENCE V (LOT# 8120841), HAS BEEN FILED UNDER MFR# 2024168-2009-01314.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY - MEDICAL INTERVENTION. REPORTING RATIONALE: DISSECTION REQUIRING MEDICAL INTERVENTION. DEVICE ISSUE: NO DEVICE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED THAT WHILE USING THE 2.75 X 23 MM XIENCE V A DISSECTION OCCURRED. THE 2.75 X 28 MM XIENCE V STENT WAS USED TO COVER THE DISSECTION, BUT FURTHER DISSECTION OCCURRED. A THIRD XIENCE V STENT WAS IMPLANTED TO TREAT THIS DISSECTION. NO ADDITIONAL EVENT OR PT INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 9021941

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention GUIDE WIRE: BMW| (LOT 8120841)| STENT: 2.75 X 23 MM XIENCE V